首页 > 最新文献

Archives of pathology & laboratory medicine最新文献

英文 中文
How Molecular Discoveries Have Changed Liver Tumor Pathology: A Brief Review. 分子发现如何改变肝脏肿瘤病理学?简要回顾。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-05-01 DOI: 10.5858/arpa.2023-0099-RA
Negar Taheri, Rondell P Graham

Context: Recent molecular discoveries have led to improved understanding of tumor biology and the development of new diagnostic assays.

Objective: To review primarily 3 examples of liver tumors and to briefly illustrate how recent molecular discoveries have altered clinical liver pathology practice.

Data sources: First, we will discuss fibrolamellar carcinoma, which will be the main focus of discussion, as an example for new diagnostic tests that have been developed as a result of molecular discoveries. Additional information on the role of molecular diagnostics in hepatocellular adenoma and hepatocellular carcinoma will be provided. Second, we will use the example of epithelioid hemangioendothelioma as an example of how new diagnostic tools, based on molecular discoveries, may support improved prognostication. Finally, we will use the example of intrahepatic cholangiocarcinoma as an example of a liver tumor where new molecular discoveries have identified tractable therapeutic targets and led to new effective therapies. This portion of the manuscript will also include a description of the anatomic and molecular differences between intrahepatic, hilar, and extrahepatic cholangiocarcinoma.

Conclusions: Fueled by molecular discoveries, new and better diagnostic tests and therapeutic targets have improved clinical care in patients affected by liver tumors.

背景:最近的分子发现提高了人们对肿瘤生物学的认识,并开发了新的诊断方法:主要回顾 3 个肝脏肿瘤实例,简要说明最新的分子发现如何改变了临床肝脏病理学实践:首先,我们将讨论纤维母细胞瘤,这将是讨论的重点,并以此为例说明由于分子发现而开发的新诊断检测方法。我们还将提供有关分子诊断在肝细胞腺瘤和肝细胞癌中的作用的补充信息。其次,我们将以上皮样血管内皮细胞瘤为例,说明基于分子发现的新诊断工具如何有助于改善预后。最后,我们将以肝内胆管癌为例,说明在肝脏肿瘤中,新的分子发现发现了可治疗的靶点,并带来了新的有效疗法。手稿的这一部分还将包括对肝内胆管癌、肝门胆管癌和肝外胆管癌之间的解剖和分子差异的描述:在分子发现的推动下,新的、更好的诊断测试和治疗目标改善了肝肿瘤患者的临床治疗。
{"title":"How Molecular Discoveries Have Changed Liver Tumor Pathology: A Brief Review.","authors":"Negar Taheri, Rondell P Graham","doi":"10.5858/arpa.2023-0099-RA","DOIUrl":"10.5858/arpa.2023-0099-RA","url":null,"abstract":"<p><strong>Context: </strong>Recent molecular discoveries have led to improved understanding of tumor biology and the development of new diagnostic assays.</p><p><strong>Objective: </strong>To review primarily 3 examples of liver tumors and to briefly illustrate how recent molecular discoveries have altered clinical liver pathology practice.</p><p><strong>Data sources: </strong>First, we will discuss fibrolamellar carcinoma, which will be the main focus of discussion, as an example for new diagnostic tests that have been developed as a result of molecular discoveries. Additional information on the role of molecular diagnostics in hepatocellular adenoma and hepatocellular carcinoma will be provided. Second, we will use the example of epithelioid hemangioendothelioma as an example of how new diagnostic tools, based on molecular discoveries, may support improved prognostication. Finally, we will use the example of intrahepatic cholangiocarcinoma as an example of a liver tumor where new molecular discoveries have identified tractable therapeutic targets and led to new effective therapies. This portion of the manuscript will also include a description of the anatomic and molecular differences between intrahepatic, hilar, and extrahepatic cholangiocarcinoma.</p><p><strong>Conclusions: </strong>Fueled by molecular discoveries, new and better diagnostic tests and therapeutic targets have improved clinical care in patients affected by liver tumors.</p>","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483878","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Debating Deposits, Redux: Substantial Interobserver Agreement Exists in Distinguishing Tumor Deposits From Nodal Metastases in Small Bowel Neuroendocrine Tumors. 沉积物之争再起波澜:在区分小肠神经内分泌肿瘤的肿瘤沉积物和结节转移方面,观察者之间的意见基本一致。
IF 3.7 3区 医学 Q2 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2024-05-01 DOI: 10.5858/arpa.2023-0169-OA
Raul S Gonzalez, Stefano La Rosa, Changqing Ma, Alexandros D Polydorides, Chanjuan Shi, Zhaohai Yang, Brian Cox, Dipti M Karamchandani

Context: Recent data suggest mesenteric tumor deposits (MTDs) indicate poor prognosis in small bowel well-differentiated neuroendocrine tumors (SB-NETs), including compared to positive lymph nodes, making their distinction crucial.

Objective: To study interobserver agreement in distinguishing SB-NET MTDs from positive nodes.

Design: Virtual slides from 36 locally metastatic SB-NET foci were shared among 7 gastrointestinal pathologists, who interpreted each as an MTD or a positive node. Observers ranked their 5 preferred choices among a supplied list of potentially useful histologic features, for both options. Diagnostic opinions were compared using Fleiss multirater and Cohen weighted κ analyses.

Results: Preferred criteria for MTD included irregular shape (n = 7, top choice for 5), perineural invasion/nerve entrapment (n = 7, top choice for 2), encased thick-walled vessels (n = 7), and prominent fibrosis (n = 6). Preferred criteria for positive nodes included peripheral lymphoid follicles (n = 6, top choice for 4), round shape (n = 7, top choice for 2), peripheral lymphocyte rim (n = 7, top choice for 1), subcapsular sinuses (n = 7), and a capsule (n = 6). Among 36 foci, 10 (28%) each were unanimously diagnosed as MTD or positive node. For 13 foci (36%), there was a diagnosis favored by most observers (5 or 6 of 7): positive node in 8, MTD in 5. Only 3 cases (8%) had a near-even (4:3) split. Overall agreement was substantial (κ = .64, P < .001).

Conclusions: Substantial interobserver agreement exists for distinguishing SB-NET MTDs from lymph node metastases. Favored histologic criteria in making the distinction include irregular shape and nerve/vessel entrapment for MTD, and peripheral lymphocytes/lymphoid follicles and round shape for positive nodes.

背景:最近的数据表明,肠系膜肿瘤沉积(MTDs)预示着小肠分化良好的神经内分泌肿瘤(SB-NETs)预后不良,包括与阳性淋巴结相比,因此区分它们至关重要:研究区分SB-NET MTD和阳性淋巴结的观察者间一致性:设计:来自 36 个局部转移性 SB-NET 病灶的虚拟切片由 7 位胃肠道病理学家共享,他们将每个病灶解释为 MTD 或阳性结节。在提供的潜在有用组织学特征列表中,观察者为这两个选项排列出 5 个首选项。采用弗莱斯多侧分析和科恩加权κ分析对诊断意见进行比较:MTD的首选标准包括形状不规则(7人,5人首选)、神经周围侵犯/神经卡压(7人,2人首选)、包裹的厚壁血管(7人)和突出的纤维化(6人)。阳性结节的首选标准包括外周淋巴滤泡(6 个,首选 4 个)、圆形(7 个,首选 2 个)、外周淋巴细胞边缘(7 个,首选 1 个)、囊下窦(7 个)和囊肿(6 个)。在 36 个病灶中,有 10 个病灶(28%)被一致诊断为 MTD 或阳性结节。对于 13 个病灶(36%),大多数观察者(7 人中的 5 或 6 人)倾向于一种诊断:8 个为阳性结节,5 个为 MTD。只有 3 个病例(8%)的诊断结果接近平均(4:3)。总体一致性很高(κ = .64, P < .001):结论:在区分 SB-NET MTD 和淋巴结转移方面,观察者之间存在很大的一致性。区分的首选组织学标准包括 MTD 的不规则形状和神经/血管夹层,以及阳性结节的外周淋巴细胞/淋巴滤泡和圆形。
{"title":"Debating Deposits, Redux: Substantial Interobserver Agreement Exists in Distinguishing Tumor Deposits From Nodal Metastases in Small Bowel Neuroendocrine Tumors.","authors":"Raul S Gonzalez, Stefano La Rosa, Changqing Ma, Alexandros D Polydorides, Chanjuan Shi, Zhaohai Yang, Brian Cox, Dipti M Karamchandani","doi":"10.5858/arpa.2023-0169-OA","DOIUrl":"10.5858/arpa.2023-0169-OA","url":null,"abstract":"<p><strong>Context: </strong>Recent data suggest mesenteric tumor deposits (MTDs) indicate poor prognosis in small bowel well-differentiated neuroendocrine tumors (SB-NETs), including compared to positive lymph nodes, making their distinction crucial.</p><p><strong>Objective: </strong>To study interobserver agreement in distinguishing SB-NET MTDs from positive nodes.</p><p><strong>Design: </strong>Virtual slides from 36 locally metastatic SB-NET foci were shared among 7 gastrointestinal pathologists, who interpreted each as an MTD or a positive node. Observers ranked their 5 preferred choices among a supplied list of potentially useful histologic features, for both options. Diagnostic opinions were compared using Fleiss multirater and Cohen weighted κ analyses.</p><p><strong>Results: </strong>Preferred criteria for MTD included irregular shape (n = 7, top choice for 5), perineural invasion/nerve entrapment (n = 7, top choice for 2), encased thick-walled vessels (n = 7), and prominent fibrosis (n = 6). Preferred criteria for positive nodes included peripheral lymphoid follicles (n = 6, top choice for 4), round shape (n = 7, top choice for 2), peripheral lymphocyte rim (n = 7, top choice for 1), subcapsular sinuses (n = 7), and a capsule (n = 6). Among 36 foci, 10 (28%) each were unanimously diagnosed as MTD or positive node. For 13 foci (36%), there was a diagnosis favored by most observers (5 or 6 of 7): positive node in 8, MTD in 5. Only 3 cases (8%) had a near-even (4:3) split. Overall agreement was substantial (κ = .64, P < .001).</p><p><strong>Conclusions: </strong>Substantial interobserver agreement exists for distinguishing SB-NET MTDs from lymph node metastases. Favored histologic criteria in making the distinction include irregular shape and nerve/vessel entrapment for MTD, and peripheral lymphocytes/lymphoid follicles and round shape for positive nodes.</p>","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":3.7,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10483880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship Program. 评估 COVID-19 大流行对 MD 安德森癌症中心解剖病理学研究员项目培训的影响。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-05-01 DOI: 10.5858/arpa.2023-0166-OA
Yiannis P Dimopoulos, DongHyang Kwon, Denái R Milton, Paula I Iaeger, Donna E Hansel, Victor G Prieto, Kareen E Chin, Phyu P Aung

Context: To provide high-quality, safe training during the COVID-19 pandemic, our anatomic pathology fellowship program implemented a hybrid virtual/in-person training model with supplemental digital material.

Objective: To evaluate the impact of this model.

Design: We examined Accreditation Council for Graduate Medical Education survey results and board pass rates for fellows before the pandemic (group 1); during the pandemic peak (group 2); and early and late after the pandemic peak (groups 3 and 4). Additionally, we distributed an online survey, including questions related to performance as attending physicians and fellowship experience, to recent graduates.

Results: Information loss during handover, supervision and teaching by faculty, and having at least 4 free days a month exhibited the greatest score declines between group 1 and groups 2, 3, and 4 on the Accreditation Council for Graduate Medical Education surveys. No differences were seen in board passing rates between groups. The groups did not differ in responses regarding preparation for role as attending, confidence in role as attending, or overall impression of the fellowship program. The pandemic-affected groups responded more positively on the perceived utility of supplemental digital material, impact of digital pathology on quality of education, and impact of supplemental digital material on familiarity with digital pathology. The difference was particularly large between group 1 and combined groups 3 and 4.

Conclusions: Despite the limitations noted, the hybrid training model was effective and successfully prepared fellows for their role as attending physicians. Similar studies can be informative for the implementation of similar programs or for the meaningful integration of digital pathology into training curricula.

背景:为了在COVID-19大流行期间提供高质量、安全的培训,我们的解剖病理学研究员项目实施了一种虚拟/面对面混合培训模式,并补充了数字材料:评估该模式的影响:设计:我们检查了毕业后医学教育认证委员会的调查结果以及大流行前(第 1 组)、大流行高峰期(第 2 组)、大流行高峰期后早期和晚期(第 3 组和第 4 组)研究员的考试通过率。此外,我们还向应届毕业生发放了一份在线调查问卷,其中包括与主治医师表现和研究经历相关的问题:结果:在毕业后医学教育认证委员会的调查中,第一组与第二、三、四组在交接班时的信息丢失、教师的监督和教学以及每月至少有 4 天的空闲时间等方面的得分下降幅度最大。各组之间的考试通过率没有差异。在对担任主治医师的准备情况、对担任主治医师的信心以及对研究金项目的总体印象的回答上,各组之间没有差异。受大流行病影响的组别对补充数字材料的实用性、数字病理学对教育质量的影响以及补充数字材料对熟悉数字病理学的影响的回答更为积极。第 1 组与第 3 组和第 4 组之间的差异尤其大:尽管存在一些局限性,但混合培训模式是有效的,并成功地帮助研究员为担任主治医师做好准备。类似的研究可为类似项目的实施或将数字病理学有意义地纳入培训课程提供参考。
{"title":"Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship Program.","authors":"Yiannis P Dimopoulos, DongHyang Kwon, Denái R Milton, Paula I Iaeger, Donna E Hansel, Victor G Prieto, Kareen E Chin, Phyu P Aung","doi":"10.5858/arpa.2023-0166-OA","DOIUrl":"10.5858/arpa.2023-0166-OA","url":null,"abstract":"<p><strong>Context: </strong>To provide high-quality, safe training during the COVID-19 pandemic, our anatomic pathology fellowship program implemented a hybrid virtual/in-person training model with supplemental digital material.</p><p><strong>Objective: </strong>To evaluate the impact of this model.</p><p><strong>Design: </strong>We examined Accreditation Council for Graduate Medical Education survey results and board pass rates for fellows before the pandemic (group 1); during the pandemic peak (group 2); and early and late after the pandemic peak (groups 3 and 4). Additionally, we distributed an online survey, including questions related to performance as attending physicians and fellowship experience, to recent graduates.</p><p><strong>Results: </strong>Information loss during handover, supervision and teaching by faculty, and having at least 4 free days a month exhibited the greatest score declines between group 1 and groups 2, 3, and 4 on the Accreditation Council for Graduate Medical Education surveys. No differences were seen in board passing rates between groups. The groups did not differ in responses regarding preparation for role as attending, confidence in role as attending, or overall impression of the fellowship program. The pandemic-affected groups responded more positively on the perceived utility of supplemental digital material, impact of digital pathology on quality of education, and impact of supplemental digital material on familiarity with digital pathology. The difference was particularly large between group 1 and combined groups 3 and 4.</p><p><strong>Conclusions: </strong>Despite the limitations noted, the hybrid training model was effective and successfully prepared fellows for their role as attending physicians. Similar studies can be informative for the implementation of similar programs or for the meaningful integration of digital pathology into training curricula.</p>","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10466148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virtual Pathology Elective, Real Education: The PathElective.com Experience as a Model for Novel Pathology Pedagogy and a Primer for Curricular Evolution. 虚拟病理学选修课,真实教育:PathElective.com 的经验是新型病理学教学法的典范和课程改革的入门读物。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-05-01 DOI: 10.5858/arpa.2022-0259-OA
Cullen M Lilley, Christina A Arnold, Michael A Arnold, Adam L Booth, Jerad M Gardner, Xiaoyin Sara Jiang, Sanam Loghavi, Kamran M Mirza

Context: PathElective.com was created in response to the pandemic's restrictions on interactions with trainees, and since has been incorporated into many training programs worldwide, serving as a unique means of delivering high-quality pathology and laboratory medical education at multiple levels of training.

Objective: To analyze student usage, performance, and satisfaction to provide insight into the effectiveness of virtual education to guide curricular evolution.

Design: Squarespace (Squarespace, Inc) was used for website development and to collect website analytics. Students were assessed before and after course participation using a dual-form crossover quiz design. Quiz data were anonymous and analyzed with a paired t test to account for varying student backgrounds. A novel analysis was performed aimed at examining the attrition rate of students across multiple modules.

Results: During the study period (May 1, 2020 to October 31, 2021), PathElective.com received 577 483 page views, 126 180 visits, 59 928 unique visitors, and 10 278 registered users who earned 15 305 certificates. A total of 7338 premodule and postmodule quiz pairs were analyzed. The overall average increase in score was 13.83% (P = .02). All but 5 of the 56 courses experienced a statistically significant increase in score. All courses received median scores of Very Satisfied/Satisfied in all 6 assessment domains. Aggregate attrition data revealed a unique, negative polynomial relationship (R2 = 0.656).

Conclusions: PathElective.com is a free, effective means of enhancing anatomic/clinical pathology training in medical education. These analyses offer a unique perspective on the online user experience and could guide the development of future online medical education resources.

背景:PathElective.com是为了应对大流行病对与学员互动的限制而创建的,此后被纳入全球许多培训项目,成为在多个培训级别提供高质量病理学和检验医学教育的独特手段:分析学生的使用情况、表现和满意度,以深入了解虚拟教育的有效性,从而指导课程的发展:设计:使用Squarespace(Squarespace公司)开发网站并收集网站分析数据。采用双形式交叉测验设计,在课程参与前后对学生进行评估。测验数据不记名,采用配对 t 检验进行分析,以考虑不同学生的背景。我们还进行了一项新颖的分析,旨在研究学生在多个模块中的流失率:在研究期间(2020 年 5 月 1 日至 2021 年 10 月 31 日),PathElective.com 的页面浏览量为 577 483 次,访问量为 126 180 次,独立访客为 59 928 人,注册用户为 10 278 人,获得证书 15 305 份。共分析了 7338 对模块前和模块后测验。总体平均得分提高了 13.83%(P = .02)。在 56 门课程中,除 5 门课程外,其他所有课程的得分都有显著提高。所有课程在所有 6 个评估领域的中位数分数均为 "非常满意"/"满意"。总减员数据显示了一种独特的负多项式关系(R2 = 0.656):PathElective.com是加强医学教育中解剖/临床病理学培训的一种免费、有效的手段。这些分析为在线用户体验提供了一个独特的视角,可以指导未来在线医学教育资源的开发。
{"title":"Virtual Pathology Elective, Real Education: The PathElective.com Experience as a Model for Novel Pathology Pedagogy and a Primer for Curricular Evolution.","authors":"Cullen M Lilley, Christina A Arnold, Michael A Arnold, Adam L Booth, Jerad M Gardner, Xiaoyin Sara Jiang, Sanam Loghavi, Kamran M Mirza","doi":"10.5858/arpa.2022-0259-OA","DOIUrl":"10.5858/arpa.2022-0259-OA","url":null,"abstract":"<p><strong>Context: </strong>PathElective.com was created in response to the pandemic's restrictions on interactions with trainees, and since has been incorporated into many training programs worldwide, serving as a unique means of delivering high-quality pathology and laboratory medical education at multiple levels of training.</p><p><strong>Objective: </strong>To analyze student usage, performance, and satisfaction to provide insight into the effectiveness of virtual education to guide curricular evolution.</p><p><strong>Design: </strong>Squarespace (Squarespace, Inc) was used for website development and to collect website analytics. Students were assessed before and after course participation using a dual-form crossover quiz design. Quiz data were anonymous and analyzed with a paired t test to account for varying student backgrounds. A novel analysis was performed aimed at examining the attrition rate of students across multiple modules.</p><p><strong>Results: </strong>During the study period (May 1, 2020 to October 31, 2021), PathElective.com received 577 483 page views, 126 180 visits, 59 928 unique visitors, and 10 278 registered users who earned 15 305 certificates. A total of 7338 premodule and postmodule quiz pairs were analyzed. The overall average increase in score was 13.83% (P = .02). All but 5 of the 56 courses experienced a statistically significant increase in score. All courses received median scores of Very Satisfied/Satisfied in all 6 assessment domains. Aggregate attrition data revealed a unique, negative polynomial relationship (R2 = 0.656).</p><p><strong>Conclusions: </strong>PathElective.com is a free, effective means of enhancing anatomic/clinical pathology training in medical education. These analyses offer a unique perspective on the online user experience and could guide the development of future online medical education resources.</p>","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens. pT1 亚分类预测膀胱肿瘤标本整体切除术的无进展生存期
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-05-01 DOI: 10.5858/arpa.2023-0044-OA
Shun Sato, Takafumi Yanagisawa, Jun Miki, Yasushi Hayashida, Yohei Okada, Kosuke Iwatani, Akihiro Matsukawa, Takahiro Kimura, Shin Egawa, Masayuki Shimoda, Hiroyuki Takahashi

Context: The pathologic diagnosis of pT1 substage in conventional transurethral resection of bladder tumor specimens is inaccurate and has low interobserver reproducibility owing to fragmentation and cauterization of the specimens. En bloc resection of bladder tumor is a novel surgical procedure that improves diagnostic feasibility and accuracy in the pathologic diagnosis of bladder cancer, including depth and extent of invasion.

Objective: To examine the prognostic value of multiple pT1 subclassification methods, using only en bloc resection specimens.

Design: We examined 106 patients with T1 bladder cancer who underwent en bloc resection. The pT1 substages were assigned by 3 different subclassification methods by using the muscularis mucosae or stalk of the papillary lesion as diagnostic landmarks or millimetric depth of invasion. Intergroup differences in progression-free survival and recurrence-free survival rates were analyzed. The prognostic values of clinicopathologic factors for progression/recurrence were analyzed by using multivariate analysis.

Results: The pT1 substage was evaluable in all cases. Tumors with invasion into/beyond the muscularis mucosae and those beyond the stalk of the papillary lesion were associated with worse progression-free survival (P = .002 and P = .01, respectively). Notably, no patient with invasion confined to the stalk had disease progression during the 23-month median follow-up period. Only the pT1 subclassification method using the muscularis mucosae was an independent prognosticator of progression in multivariate analysis (P = .03).

Conclusions: Precise pathologic subclassification of invasion using en bloc resection specimens may enable accurate prognosis and assessment in patients with bladder cancer with suspicious shallow invasion.

背景:传统经尿道膀胱肿瘤切除术标本的病理诊断 pT1 亚分期不准确,而且由于标本破碎和烧灼,观察者之间的可重复性很低。膀胱肿瘤整体切除术是一种新型手术方法,可提高膀胱癌病理诊断的可行性和准确性,包括侵犯深度和范围:仅使用全切标本研究多种 pT1 亚分类方法的预后价值:我们对 106 名接受全切的 T1 膀胱癌患者进行了研究。采用3种不同的亚分类方法,以粘膜肌肉或乳头状病变的柄部作为诊断标志或以毫米为单位的浸润深度来划分pT1亚型。分析了无进展生存率和无复发生存率的组间差异。采用多变量分析法对临床病理因素对进展/复发的预后价值进行了分析:结果:所有病例的 pT1 亚分期均可评估。肿瘤侵犯粘膜肌层或超出粘膜肌层以及超出乳头状病变柄的肿瘤与较差的无进展生存期相关(分别为 P = .002 和 P = .01)。值得注意的是,在23个月的中位随访期间,没有一名侵犯范围局限于柄部的患者出现疾病进展。在多变量分析中,只有使用粘膜肌的pT1亚分类方法是疾病进展的独立预后指标(P = .03):结论:使用整体切除标本对侵犯进行精确的病理亚分类,可对可疑浅表侵犯的膀胱癌患者进行准确的预后和评估。
{"title":"pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.","authors":"Shun Sato, Takafumi Yanagisawa, Jun Miki, Yasushi Hayashida, Yohei Okada, Kosuke Iwatani, Akihiro Matsukawa, Takahiro Kimura, Shin Egawa, Masayuki Shimoda, Hiroyuki Takahashi","doi":"10.5858/arpa.2023-0044-OA","DOIUrl":"10.5858/arpa.2023-0044-OA","url":null,"abstract":"<p><strong>Context: </strong>The pathologic diagnosis of pT1 substage in conventional transurethral resection of bladder tumor specimens is inaccurate and has low interobserver reproducibility owing to fragmentation and cauterization of the specimens. En bloc resection of bladder tumor is a novel surgical procedure that improves diagnostic feasibility and accuracy in the pathologic diagnosis of bladder cancer, including depth and extent of invasion.</p><p><strong>Objective: </strong>To examine the prognostic value of multiple pT1 subclassification methods, using only en bloc resection specimens.</p><p><strong>Design: </strong>We examined 106 patients with T1 bladder cancer who underwent en bloc resection. The pT1 substages were assigned by 3 different subclassification methods by using the muscularis mucosae or stalk of the papillary lesion as diagnostic landmarks or millimetric depth of invasion. Intergroup differences in progression-free survival and recurrence-free survival rates were analyzed. The prognostic values of clinicopathologic factors for progression/recurrence were analyzed by using multivariate analysis.</p><p><strong>Results: </strong>The pT1 substage was evaluable in all cases. Tumors with invasion into/beyond the muscularis mucosae and those beyond the stalk of the papillary lesion were associated with worse progression-free survival (P = .002 and P = .01, respectively). Notably, no patient with invasion confined to the stalk had disease progression during the 23-month median follow-up period. Only the pT1 subclassification method using the muscularis mucosae was an independent prognosticator of progression in multivariate analysis (P = .03).</p><p><strong>Conclusions: </strong>Precise pathologic subclassification of invasion using en bloc resection specimens may enable accurate prognosis and assessment in patients with bladder cancer with suspicious shallow invasion.</p>","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10218821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Cancer Biomarkers Conference: Pathologists Leading the Molecular Testing Discussion. 癌症生物标志物会议:病理学家引领分子检测讨论。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-04-25 DOI: 10.5858/arpa.2023-0175-ED
Timothy Craig Allen
{"title":"The Cancer Biomarkers Conference: Pathologists Leading the Molecular Testing Discussion.","authors":"Timothy Craig Allen","doi":"10.5858/arpa.2023-0175-ED","DOIUrl":"https://doi.org/10.5858/arpa.2023-0175-ED","url":null,"abstract":"","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Reply. 回复中。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-04-25 DOI: 10.5858/arpa.2024-0067-LE
A. C. Mackinnon, Shuko Harada
{"title":"In Reply.","authors":"A. C. Mackinnon, Shuko Harada","doi":"10.5858/arpa.2024-0067-LE","DOIUrl":"https://doi.org/10.5858/arpa.2024-0067-LE","url":null,"abstract":"","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clarification of Information in "Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance Tests". 下一代测序实验室开发检验导航 "中的信息澄清:对能力验证、美国食品药品管理局法规和临床实验室性能测试的批判性审视》中的信息。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-04-25 DOI: 10.5858/arpa.2023-0593-LE
C. M. Lockwood
{"title":"Clarification of Information in \"Navigating Next-Generation Sequencing Laboratory Developed Tests: A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance Tests\".","authors":"C. M. Lockwood","doi":"10.5858/arpa.2023-0593-LE","DOIUrl":"https://doi.org/10.5858/arpa.2023-0593-LE","url":null,"abstract":"","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140658713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinicopathological Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology. PIT1和SF1多系垂体神经内分泌肿瘤的临床病理相关性及NKX2.2免疫组化在垂体病理学中的诊断作用
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-04-23 DOI: 10.5858/arpa.2023-0543-OA
F. M. Doğukan, Hüseyin Karatay, Sabahattin Yüzkan, Şebnem Burhan, Buruç Erkan, Banu Yılmaz-Özgüven
CONTEXT.—PIT1 and SF1-multilineage pituitary neuroendocrine tumors (PitNETs) have been defined since the classification of adenohypophysial tumors based on the PIT1, SF1, and TPIT transcription factors.OBJECTIVE.—To describe the clinicopathologic features of PIT1 and SF1-multilineage PitNETs and to contribute to the pituitary pathology practice by questioning the expression of NKX2.2 in PitNETs.DESIGN.—We reviewed 345 PitNETs and described the clinicopathologic features of 8 PIT1 and SF1-multilineage tumors. NKX2.2 positivity and staining pattern were compared to those of 45 PitNETs from the control group.RESULTS.—PIT1 and SF1-multilineage PitNET patients had a mean age of 41.13 (range, 14-58 years) and a mean diameter of 14.0 mm (range, 8-20 mm). The most common clinical presentation was acromegaly (6 of 8), and postoperative remission was achieved in all patients. On histomorphologic examination, a pseudopapillary pattern was seen in 5 of the tumors, either focally or diffusely. In addition to PIT1 and SF1, there was a diffuse staining with growth hormone and a predominantly perinuclear staining with cytokeratin 18. With NKX2.2, all multilineage tumors were positive, of which 5 were diffuse and 3 were focal. In the control group, 8 tumors (8 of 45) were positive, of which only 1 was diffuse and 7 were focal.CONCLUSIONS.—In conclusion, NKX2.2 is a transcription factor that can be used as an additional tool in pituitary pathology, and PIT1 and SF1-multilineage PitNETs are specific tumors that usually present with acromegaly, show signs of a nonaggressive clinical course, have a pseudopapillary histomorphology, and express NKX2.2.
目的:描述PIT1和SF1-多系垂体神经内分泌肿瘤(PitNETs)的临床病理特征,并通过质疑NKX2.N的表达为垂体病理学实践做出贡献。-通过质疑NKX2.2在PitNETs中的表达,描述PIT1和SF1多系PitNETs的临床病理特征,并为垂体病理学实践做出贡献。设计:我们回顾了345例PitNETs,描述了8例PIT1和SF1多系肿瘤的临床病理特征。结果:PIT1和SF1-多线型PitNET患者的平均年龄为41.13岁(14-58岁),平均直径为14.0毫米(8-20毫米)。最常见的临床表现是肢端肥大症(8 例中有 6 例),所有患者均实现了术后缓解。在组织形态学检查中,5 例肿瘤出现了假乳头状形态,有的呈局灶性,有的呈弥漫性。除 PIT1 和 SF1 外,生长激素也有弥漫性染色,细胞角蛋白 18 主要呈核周染色。NKX2.2方面,所有多线瘤均呈阳性,其中5个为弥漫性,3个为局灶性。结论:总之,NKX2.2是一种转录因子,可作为垂体病理学的额外工具,PIT1和SF1-多线型PitNET是特异性肿瘤,通常伴有肢端肥大症,临床表现为非侵袭性病程,具有假乳头组织形态学,并表达NKX2.2。
{"title":"Clinicopathological Correlates of PIT1 and SF1-Multilineage Pituitary Neuroendocrine Tumors and the Diagnostic Utility of NKX2.2 Immunohistochemistry in Pituitary Pathology.","authors":"F. M. Doğukan, Hüseyin Karatay, Sabahattin Yüzkan, Şebnem Burhan, Buruç Erkan, Banu Yılmaz-Özgüven","doi":"10.5858/arpa.2023-0543-OA","DOIUrl":"https://doi.org/10.5858/arpa.2023-0543-OA","url":null,"abstract":"CONTEXT.—\u0000PIT1 and SF1-multilineage pituitary neuroendocrine tumors (PitNETs) have been defined since the classification of adenohypophysial tumors based on the PIT1, SF1, and TPIT transcription factors.\u0000\u0000\u0000OBJECTIVE.—\u0000To describe the clinicopathologic features of PIT1 and SF1-multilineage PitNETs and to contribute to the pituitary pathology practice by questioning the expression of NKX2.2 in PitNETs.\u0000\u0000\u0000DESIGN.—\u0000We reviewed 345 PitNETs and described the clinicopathologic features of 8 PIT1 and SF1-multilineage tumors. NKX2.2 positivity and staining pattern were compared to those of 45 PitNETs from the control group.\u0000\u0000\u0000RESULTS.—\u0000PIT1 and SF1-multilineage PitNET patients had a mean age of 41.13 (range, 14-58 years) and a mean diameter of 14.0 mm (range, 8-20 mm). The most common clinical presentation was acromegaly (6 of 8), and postoperative remission was achieved in all patients. On histomorphologic examination, a pseudopapillary pattern was seen in 5 of the tumors, either focally or diffusely. In addition to PIT1 and SF1, there was a diffuse staining with growth hormone and a predominantly perinuclear staining with cytokeratin 18. With NKX2.2, all multilineage tumors were positive, of which 5 were diffuse and 3 were focal. In the control group, 8 tumors (8 of 45) were positive, of which only 1 was diffuse and 7 were focal.\u0000\u0000\u0000CONCLUSIONS.—\u0000In conclusion, NKX2.2 is a transcription factor that can be used as an additional tool in pituitary pathology, and PIT1 and SF1-multilineage PitNETs are specific tumors that usually present with acromegaly, show signs of a nonaggressive clinical course, have a pseudopapillary histomorphology, and express NKX2.2.","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140669811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Democratizing Artificial Intelligence in Anatomic Pathology. 解剖病理学中的人工智能民主化。
IF 4.6 3区 医学 Q1 Health Professions Pub Date : 2024-04-23 DOI: 10.5858/arpa.2023-0205-OA
Thomas J. Flotte, Stephanie A. Derauf, Rachel K Byrd, T. Kroneman, Debra A Bell, Lucas Stetzik, Seung-Yi Lee, Alireza Samiei, Steven N Hart, Joaquin J Garcia, Gillian Beamer, Thomas Westerling-Bui
CONTEXT.—Artificial intelligence is a transforming technology for anatomic pathology. Involvement within the workforce will foster support for algorithm development and implementation.OBJECTIVE.—To develop a supportive ecosystem that enables pathologists with variable expertise in artificial intelligence to create algorithms in a development environment with seamless transition to a production environment.DESIGN.—RESULTS.—The development team considered internal development and vended solutions. Because of the extended timeline and resource requirements for internal development, a decision was made to use a vended solution. Vendor proposals were solicited and reviewed by pathologists, IT, and security groups. A vendor was selected and pipelines for development and production were established. Proposals for development were solicited from the pathology department. Eighty-four investigators were selected for the initial cohort, receiving training and access to dedicated subject matter experts. A total of 30 of 31 projects progressed through the model development process of annotating, training, and validation. Based on these projects, 15 abstracts were submitted to national meetings.CONCLUSIONS.—Democratizing artificial intelligence by creating an ecosystem to support pathologists with varying levels of expertise can break down entry barriers, reduce overall cost of algorithm development, improve algorithm quality, and enhance the speed of adoption.
背景:人工智能是解剖病理学的一项变革性技术。目标:开发一个支持性生态系统,使具有不同人工智能专业知识的病理学家能够在开发环境中创建算法,并无缝过渡到生产环境。由于内部开发需要更长的时间和更多的资源,因此决定使用自动售货机解决方案。病理学家、IT 和安全小组征求并审查了供应商的建议。选定了一家供应商,并建立了开发和生产管道。向病理部门征集开发提案。84 名研究人员被选入初始组群,接受了培训并获得了专门的主题专家的帮助。在 31 个项目中,共有 30 个项目通过了注释、培训和验证等模型开发流程。结论:通过创建一个生态系统来支持具有不同专业水平的病理学家,实现人工智能的民主化,可以打破准入门槛、降低算法开发的总体成本、提高算法质量并加快采用速度。
{"title":"Democratizing Artificial Intelligence in Anatomic Pathology.","authors":"Thomas J. Flotte, Stephanie A. Derauf, Rachel K Byrd, T. Kroneman, Debra A Bell, Lucas Stetzik, Seung-Yi Lee, Alireza Samiei, Steven N Hart, Joaquin J Garcia, Gillian Beamer, Thomas Westerling-Bui","doi":"10.5858/arpa.2023-0205-OA","DOIUrl":"https://doi.org/10.5858/arpa.2023-0205-OA","url":null,"abstract":"CONTEXT.—\u0000Artificial intelligence is a transforming technology for anatomic pathology. Involvement within the workforce will foster support for algorithm development and implementation.\u0000\u0000\u0000OBJECTIVE.—\u0000To develop a supportive ecosystem that enables pathologists with variable expertise in artificial intelligence to create algorithms in a development environment with seamless transition to a production environment.\u0000\u0000\u0000DESIGN.—\u0000\u0000\u0000\u0000RESULTS.—\u0000The development team considered internal development and vended solutions. Because of the extended timeline and resource requirements for internal development, a decision was made to use a vended solution. Vendor proposals were solicited and reviewed by pathologists, IT, and security groups. A vendor was selected and pipelines for development and production were established. Proposals for development were solicited from the pathology department. Eighty-four investigators were selected for the initial cohort, receiving training and access to dedicated subject matter experts. A total of 30 of 31 projects progressed through the model development process of annotating, training, and validation. Based on these projects, 15 abstracts were submitted to national meetings.\u0000\u0000\u0000CONCLUSIONS.—\u0000Democratizing artificial intelligence by creating an ecosystem to support pathologists with varying levels of expertise can break down entry barriers, reduce overall cost of algorithm development, improve algorithm quality, and enhance the speed of adoption.","PeriodicalId":8305,"journal":{"name":"Archives of pathology & laboratory medicine","volume":null,"pages":null},"PeriodicalIF":4.6,"publicationDate":"2024-04-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140670024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of pathology & laboratory medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1